Wikidata

(Q65353592)

English

Open-Label Safety Study of ADS-5102 in PD Patients With LID

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
Open-Label Safety Study of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia (LID) (English)
0 references
country
Austria
0 references
Canada
0 references
France
0 references
Germany
0 references
Spain
0 references
start time
July 2014
0 references
end time
March 2018
0 references
number of participants
250
0 references
minimum age
30 year
0 references
maximum age
85 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65353592&oldid=2245648295"